Apyx Medical (NASDAQ:APYX) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Apyx Medical (NASDAQ:APYX) posted its quarterly earnings data on Thursday. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.02, Zacks reports. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. Apyx Medical updated its FY 2025 guidance to EPS.

Apyx Medical Trading Up 0.5 %

APYX stock opened at $1.07 on Thursday. The company has a debt-to-equity ratio of 3.03, a current ratio of 5.46 and a quick ratio of 4.52. The stock has a market capitalization of $40.28 million, a price-to-earnings ratio of -1.29 and a beta of 1.18. The business has a fifty day moving average price of $1.43 and a 200 day moving average price of $1.38. Apyx Medical has a fifty-two week low of $0.97 and a fifty-two week high of $1.99.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.